Derivatization of enolic OH of piroxicam: A comparative study on esters and sulfonates

被引：15

作者：

Jayaselli, J. ^{[1
]}

Cheemala, J. Manila Sagar ^{[1
]}

Geetha, Rani D. P. ^{[1
]}

Pal, Sarbani ^{[1
]}

机构：

[1] MNR Post Grad Coll, Dept Chem, Hyderabad, Andhra Pradesh, India

来源：

JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY | 2008年 / 19卷 / 03期

关键词：

piroxicam; esters; sulfonates; cyclooxygenase;

D O I：

10.1590/S0103-50532008000300019

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A number of ester and sulfonate derivatives of piroxicam were prepared via acylation/sulfonation of the enolic OH of piroxicam. All the compounds were evaluated for their chemical stability and cyclooxygenase inhibiting properties. Data suggested that esters could be useful for the development of potential prodrugs. The sulfonate derivatives prepared for the first time were found to be stable. One of them showed a moderately selective COX-2 inhibition over COX-1 and would have lower gastrointestinal side effects than piroxicam due to the masked enolic OH group. A plausible mechanism for the acylation/sulfonation process has been proposed that involves participation of the pyridine moiety of piroxicam. Molecular structure of one of the ester was established for the first time by the crystal structure analysis from X-ray powder data.

引用

页码：509 / 515

页数：7

共 25 条

[1]

Andrade SM, 1996, PROG COLL POL SCI S, V100, P195

[2] Hydrogen bonding effects in the photophysics of a drug, Piroxicam, in homogeneous media and dioxane-water mixtures [J].

Andrade, SM ;

Costa, SMB .

PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 1999, 1 (18) :4213-4218

[3]

Andrade SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P405, DOI 10.1562/0031-8655(2000)071<0405:TIOWOT>2.0.CO

[4]

[5] Host-guest complexation of oxicam NSAIDs with β-cyclodextrin [J].

Banerjee, R ;

Chakraborty, H ;

Sarkar, M .

BIOPOLYMERS, 2004, 75 (04) :355-365

[6]

BUNDGAARD H, 1991, Drugs of the Future, V16, P443

[7]

BURCH RM, 1983, J PHARMACOL EXP THER, V227, P84

[8] INHIBITION OF HUMAN NEUTROPHIL ELASTASE .3. AN ORALLY-ACTIVE ENOL ACETATE PRODRUG [J].

BURKHART, JP ;

KOEHL, JR ;

MEHDI, S ;

DURHAM, SL ;

JANUSZ, MJ ;

HUBER, EW ;

ANGELASTRO, MR ;

SUNDER, S ;

METZ, WA ;

SHUM, PW ;

CHEN, TM ;

BEY, P ;

CREGGE, RJ ;

PEET, NP .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :223-233

[9] Crystal and molecular structure analysis of 4-o-(4-methoxybenzoyl)-2-methyl-N-(2-pyridal)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide from laboratory X-ray powder data [J].

Chakraborty, Santu ;

Ghosh, Soumen ;

Cheemala, J. Manilla Sagar ;

Jayaselli, Jagadeesan ;

Pal, Sarbani ;

Mukherjee, Alok Kumar .

ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 2007, 222 (08) :437-442

[10] MECHANISM OF SELECTIVE-INHIBITION OF THE INDUCIBLE ISOFORM OF PROSTAGLANDIN G/H SYNTHASE [J].

COPELAND, RA ;

WILLIAMS, JM ;

GIANNARAS, J ;

NURNBERG, S ;

COVINGTON, M ;

PINTO, D ;

PICK, S ;

TRZASKOS, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11202-11206

← 1 2 3 →